Doctor profile · Federal record
Dr. Aderonke Ajala, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · State College, PA
- NPI 1689015042
- Accepts Medicare
- MIPS 95.3 / 100 · 2023
- 18 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
235 Wellness Way
State College, PA 168036709
(814) 231-7800
fax (814) 231-7098 - Additional location
-
1800 E Park Ave
State College, PA 168036701
fax (814) 231-7295 - Mailing address
-
155 Wellness Way
State College, PA 168036797
Credentials & registration
- NPI registered
- July 2013 — 13 yrs on file
- Profile last updated
- May 12, 2025
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Pennsylvania #MD468171
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1689015042. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
74,470
Distinct HCPCS
10
Medicare allowed
$1,031,715
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 20,910 | 27 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 11,200 | 16 | $54 | |
J9267 |
Injection, paclitaxel, 1 mg | 9,510 | 15 | $0 | |
J1453 |
Injection, fosaprepitant, 1 mg | 9,300 | 21 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 7,800 | 14 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 5,940 | 20 | $23 | |
J9030 |
Bcg live intravesical instillation, 1 mg | 2,142 | 13 | $3 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 1,670 | 12 | $34 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,260 | 39 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 920 | 32 | $1 |
In context: peer comparison
Among 1 peers in State College Hematology & Oncology Physician, average services per provider: 1,909. This provider delivers 39× the peer median.Open Payments
Industry payments received
All-time total
$355
Transactions
17
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $104.39 | |
| Daiichi Sankyo INC. | 2 | $58.74 | |
| Takeda Pharmaceuticals U.S.A., INC. | 1 | $39.67 | |
| Celgene Corporation | 2 | $32.54 | |
| Pfizer INC. | 2 | $30.10 | |
| TerSera Therapeutics LLC | 1 | $22.51 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $18.60 | |
| Gilead Sciences, INC. | 1 | $18.15 | |
| Regeneron Healthcare Solutions, INC. | 1 | $17.02 | |
| GlaxoSmithKline, LLC. | 1 | $13.72 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,233
Patients
409
Total drug cost
$456,888
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 222 | 65 | $6,334 |
| Prednisone | Generic | 157 | 41 | $1,002 |
| Tamoxifen Citrate | Generic | 134 | 32 | $4,606 |
| Ondansetron Hcl | Generic | 118 | 62 | $905 |
| Abiraterone Acetate | Generic | 87 | 17 | $352,311 |
| Oxycodone Hcl | Generic | 73 | 30 | $1,940 |
| Dexamethasone | Generic | 72 | 36 | $1,498 |
| Eliquis (Apixaban) | Brand | 71 | 20 | $50,053 |
| Prochlorperazine Maleate | Generic | 65 | 53 | $1,366 |
| Hydroxyurea | Generic | 52 | 12 | $1,535 |
Hospital affiliations
Frequently asked questions
What is Dr. Aderonke Ajala's medical specialty?
Dr. Aderonke Ajala practices Hematology & Oncology Physician in State College, PA.
Where does Dr. Aderonke Ajala practice?
Dr. Aderonke Ajala practices at 235 Wellness Way, State College, PA 168036709. Office phone: 8142317800.
What is Dr. Aderonke Ajala's NPI?
Dr. Aderonke Ajala's National Provider Identifier (NPI) is 1689015042, issued by NPPES.
Does Dr. Aderonke Ajala accept Medicare assignment?
Yes. Dr. Aderonke Ajala accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Aderonke Ajala commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, paclitaxel, 1 mg (HCPCS J9267). Source: CMS Medicare Physician & Other Practitioners file.